Moderate Symptom-Based Exacerbations as Predictors of Severe Claims-Based Exacerbations in Asthma

References

• Weiss KB, Sullivan SD. The health economics of asthma and rhinitis. Assessing the economic impact. J Allergy Clin Immunol 2001; 107(1):3–8.
   PubMed Web of Science ®Google Scholar
• Barnett SB, Nurmagambetov TA. Costs of asthma in the United States: 2002–2007. J Allergy Clin Immunol 2011; 127(1):145–152.
   PubMed Web of Science ®Google Scholar
• Global Strategy for Asthma Management and Prevention (2010). Global Initiative for Asthma (GINA). Available at: http://www.ginasthma.org/guideline-report-2010.html. Accessed March 15, 2012.
   Google Scholar
• Reddel HK, Taylor DR, Bateman ED, Boulet L, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, Johan C, de Jongste JC, Kerstjens HA, Lazarus SC, Levy ML, O’Byrne PM, Partridge MR, Pavord ID, Sears MR, Sterk PJ, Stoloff SW, Sullivan SD, Szefler SJ, Thomas MD, Wenzel SE. An official American Thoracic Society/European Respiratory Society Statement: Asthma control and exacerbations. Am J Respir Crit Care Med 2009; 180:59–99.
   PubMed Web of Science ®Google Scholar
• National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): Guidelines for the diagnosis and management of asthma. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute, 2007.
   Google Scholar
• Chan-Yeung M, Chang JH, Manfreda J, Ferguson A, Becker A. Changes in peak flow, symptom score, and the use of medications during acute exacerbations of asthma. Am J Respir Crit Care Med 1996; 154(4 Pt 1):889–893.
   PubMedGoogle Scholar
• Lalloo UG, Malolepszy J, Kozma D, Krofta K, Ankerst J, Johansen B, Thomson NC. Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma. Chest 2003; 123(5):1480–1487.
   PubMedGoogle Scholar
• O’Byrne PM, Barnes PJ, Rodriguez-Roisin R, Runnerstrom E, Sandstrom T, Svensson K, Tattersfield AE. Low dose inhaled budesonide and formoterol in mild persistent asthma: The OPTIMA randomized trial. Am J Respir Crit Care Med 2001; 164(8 Pt 1):1392–1397.
   PubMed Web of Science ®Google Scholar
• Pauwels R, Lofdahl CG, Postma DS, Tattersfield AE, O’Byrne PM, Barnes PJ, Ullman A. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997; 337(20):1405–1411.
   PubMed Web of Science ®Google Scholar
• Reddel HK, Jenkins CR, Marks GB, Ware SI, Xuan W, Salome CM, Badcock C-A, Woolcock AJ. Optimal asthma control, starting with high doses of inhaled budesonide. Eur Respir J 2000; 16(2):226–235.
   PubMedGoogle Scholar
• Fuhlbrigge AL, Peden D, Apter AJ, Boushey HA, Camargo CA, Gern J, Heymann PW, Martinez FD, Mauger D, Teague WG, Blaisdell C. Asthma outcomes: Exacerbations. J Allergy Clin Immunol 2012; 129(3):S34–S49.
   PubMed Web of Science ®Google Scholar
• Heinig JH, Boulet LP, Croonenborghs L, Mollers MJ. The effect of high-dose fluticasone propionate and budesonide on lung function and asthma exacerbations in patients with severe asthma. Respir Med 1999; 93(9):613–620.
   PubMed Web of Science ®Google Scholar
• Virchow JC, Prasse A, Naya, Summerton L, Harris A. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids. Am J Respir Crit Care Med 2000; 162(2 Pt 1):578–585.
   PubMed Web of Science ®Google Scholar
• Ng TP. Validity of symptom and clinical measures of asthma severity for primary outpatient assessment of adult asthma. Br J Gen Pract 2000; 50:7–12.
   PubMedGoogle Scholar
• Malo JL, L’Archeveque J, Trudeau C, d’Aquino C, Cartier A. Should we monitor peak expiratory flow rates or record symptoms with a simple diary in management of asthma? J Allergy Clin Immunol 1993; 91(3):702–709.
   PubMedGoogle Scholar
• Partnership for Solutions. Asthma: The impact of multiple chronic conditions. Baltimore, MD: Partnership for Solutions, 2004. Available at: http://www.partnershipforsolutions.org/. Accessed October 10, 2011.
   Google Scholar
• Gibson PG, Powell H, Wilson AJ, Abramson MJ, Haywood P, Bauman A, Hensley MJ, Walters EH, Roberts. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev 2003; (1): CD001117.
   Google Scholar
• Vollmer WM, Markson LE, O’Connor E, Sanocki LL, Fitterman L, Berger M, Buist AS. Association of asthma control with health care utilization and quality of life. Am J Respir Crit Care Med 1999; 160(5 Pt 1):1647–1652.
   PubMed Web of Science ®Google Scholar
• Miller MK, Lee JH, Miller DP, Wenzel SE, TENOR Study Group. Recent asthma exacerbations: A key predictor of future exacerbations. Respir Med 2007; 101(3):481–489.
   PubMed Web of Science ®Google Scholar
• Smith DH, Malone DC, Lawson KA, Okamoto LJ, Battista C, Saunders WB. A national estimate of the economic costs of asthma. Am J Respir Crit Care Med 1997; 156(3 Pt 1):787–793.
   PubMed Web of Science ®Google Scholar
• Stempel DA, McLaughin TP, Stanford RH, Fuhlbrigge AL. Patterns of asthma control: A 3-year analysis of patient claims. J Allergy Clin Immunol 2005; 115(5):935–939.
   PubMed Web of Science ®Google Scholar